HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombolytic therapy in acute myocardial infarction following prolonged cardiopulmonary resuscitation.

Abstract
Thrombolytic therapy was administered to a 49-year-old woman with an acute anterior wall myocardial infarction after having prolonged cardiopulmonary resuscitation for 13 minutes. On admission, there was no clinical or radiographic evidence of gross trauma. There was no significant morbidity and the patient recovered to a completely functional status. The literature of thrombolytic therapy after cardiopulmonary resuscitation is reviewed. In the absence of gross trauma from cardiopulmonary resuscitation, thrombolytic therapy in acute myocardial infarction should not necessarily be excluded because of the duration of resuscitation. Further experience with such patients will shed additional light on efficacy and safety.
AuthorsR B Neches, A M Goldfarb, G J Saviano
JournalClinical cardiology (Clin Cardiol) Vol. 14 Issue 7 Pg. 616-9 (Jul 1991) ISSN: 0160-9289 [Print] United States
PMID1747973 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Heparin
  • Tissue Plasminogen Activator
  • Aspirin
Topics
  • Aspirin (therapeutic use)
  • Cardiopulmonary Resuscitation
  • Electrocardiography
  • Female
  • Heparin (therapeutic use)
  • Humans
  • Middle Aged
  • Myocardial Infarction (drug therapy, physiopathology, therapy)
  • Thrombolytic Therapy
  • Time Factors
  • Tissue Plasminogen Activator (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: